絞り込み

17307

広告

「"Svenningsson P "[Author]」の検索結果

293件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

A randomized placebo-controlled PET study of ketamine´s effect on serotonin receptor binding in patients with SSRI-resistant depression.

NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism.

[Orthostatic tremor - a disregarded diagnosis].

Modulation of Ion Channels and Receptors by p11 (S100A10).

Effects of a novel psychomotor stabilizer, IRL790, on biochemical measures of synaptic markers and neurotransmission.

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.

Feasibility Aspects of Exploring Exercise-Induced Neuroplasticity in Parkinson's Disease: A Pilot Randomized Controlled Trial.

Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37.

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses.

Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci.

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.

Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson's Disease: A Randomized Controlled Trial.

[Recent advances in Huntington's disease].

[Parkinson's disease - heterogeneous and complex in its clinical presentation].

[Ataxia - a group of heterogeneous diseases].

Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27.

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohort.

Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy.

The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson's disease: a study protocol for a double-blinded randomized controlled trial.

Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります